ArticleJournal of medical case reports2026
Primary cardiac angiosarcoma with isolated superior vena cava syndrome: a case report.
Article in Journal of medical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPrimary cardiac angiosarcoma is a rare and malignant tumor that most often arises in the right atrium causing significant inflow obstruction and circulatory disruption. Owing to its location, it is most often associated with symptoms similar to heart failure including lower extremity swelling, dyspnea, and chest pain. Other symptoms of venous congestion, including superior vena cava syndrome, are possible but symptoms vary widely depending on the location and size of the tumor and are rarely isolated. CASE PRESENTATION: In this case, a 69-year-old Filipino American female presented to our facility with isolated findings of superior vena cava syndrome that were ultimately secondary to cardiac angiosarcoma. The patient developed recurrent pericardial effusions that necessitated drain placement. She was managed with medical, chemotherapeutic, and radiation therapy in the outpatient setting. She subsequently was found to have worsening of metastatic disease that resulted in her passing.
conclusionPatients with cardiac angiosarcoma may present with atypical or nonspecific symptoms, such as with our patient presenting with isolated superior vena cava syndrome, and an atypical presentation may further delay the diagnosis. Late presenting cardiac angiosarcoma contributes to a worse prognosis and higher likelihood of metastasis at the time of diagnosis. Treatment typically includes chemotherapy and radiation but surgical excision, alone or in combination with other therapies, can provide the best prognosis. Early detection of cardiac angiosarcoma is crucial for improving outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.